Peer-influenced content. Sources you trust. No registration required. This is HCN.
Annals of the Rheumatic Diseases (ARD)
A first joint EULAR/PReS guideline unifies systemic juvenile idiopathic arthritis and adult-onset Still’s disease under a single name, Still’s disease, and recommends early IL-1 or IL-6 inhibitor therapy over prolonged glucocorticoid use.
Pediatric Hematology/Oncology June 30th 2026
Sleep-Wake Advisor
A supervised random forest classifier trained on 330 features derived from nocturnal polysomnography achieved areas under the ROC curve approaching or exceeding 0.8 for distinguishing narcolepsy type 2, idiopathic hypersomnia, and controls in a national French reference database.
Neurology June 23rd 2026
JNP: The Journal for Nurse Practitioners
A 14-year-old athlete presenting with exertional dyspnea and partial albuterol response prompted a structured biopsychosocial workup that revealed anxiety disorder rather than exercise-induced asthma as the primary driver.
Adolescent Medicine June 18th 2026
Pulmonology Advisor
The GINA 2026 update introduces age-stratified primary care flowcharts for asthma exacerbation management, expands biologic guidance including depemokimab, and adds a formal red-flag list for fatal or near-fatal asthma risk in adults and adolescents.
Adolescent Medicine June 17th 2026
The 2026 Surviving Sepsis Campaign pediatric guidelines issued 61 recommendations covering infection recognition, hemodynamics, ventilation, and long-term follow-up for children with sepsis or septic shock.
Emergency Medicine June 3rd 2026
MDLinx
Invasive mucinous adenocarcinoma carries elevated NRG1 fusion burden that standard DNA-based sequencing reliably misses, while an FDA-approved targeted therapy now exists for confirmed cases.
Hematology/Oncology May 12th 2026